A Novel Predictor Tool of Biochemical Recurrence after Radical Prostatectomy Based on a Five-MicroRNA Tissue Signature

Within five to ten years after radical prostatectomy (RP), approximately 15–34% of prostate cancer (PCa) patients experience biochemical recurrence (BCR), which is defined as recurrence of serum levels of prostate-specific antigen >0.2 µg/L, indicating probable cancer recurrence. Models using cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Zhongwei, Weickmann, Sabine, Jung, Monika, Lein, Michael, Kilic, Ergin, Stephan, Carsten, Erbersdobler, Andreas, Fendler, Annika, Jung, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826532/
https://www.ncbi.nlm.nih.gov/pubmed/31640261
http://dx.doi.org/10.3390/cancers11101603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826532/
https://www.ncbi.nlm.nih.gov/pubmed/31640261
http://dx.doi.org/10.3390/cancers11101603

Ejemplares similares